Nivalis Therapeutics Net Profit Margin 2013-2020 | ALPN

Nivalis Therapeutics net profit margin from 2013 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Nivalis Therapeutics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.00B $-0.03B -1100.00%
2020-03-31 $0.00B $-0.04B -1166.67%
2018-06-30 $0.00B $-0.02B inf%
2018-03-31 $0.00B $-0.01B -1100.00%
2017-12-31 $0.00B $-0.01B -400.00%
2017-09-30 $0.00B $0.01B 275.00%
2017-06-30 $0.01B $0.01B 180.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.193B $0.002B
Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.617B 43.58
Takeda Pharmaceutical (TAK) Japan $59.051B 10.29
Astellas Pharma (ALPMY) Japan $28.374B 14.38
Eisai (ESALY) Japan $26.495B 22.39
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $18.572B 24.36
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.816B 45.01
Grifols, S.A (GRFS) Spain $11.427B 13.97
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.439B 36.54
IPSEN SA ADR (IPSEY) France $9.086B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.993B 13.22
Ionis Pharmaceuticals (IONS) United States $7.232B 45.81
Orion OYJ (ORINY) Finland $7.077B 24.56
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.852B 0.00
United Therapeutics (UTHR) United States $4.711B 10.89
Evotec AG (EVTCY) Germany $4.121B 143.05
FibroGen (FGEN) United States $4.068B 0.00
Hypermarcas (HYPMY) Brazil $3.774B 13.88
ChemoCentryx (CCXI) United States $3.698B 0.00
Nektar Therapeutics (NKTR) United States $3.633B 0.00
PTC Therapeutics (PTCT) United States $3.170B 0.00
Sage Therapeutics (SAGE) United States $3.074B 0.00
Pacira BioSciences (PCRX) United States $2.578B 67.76
Xencor (XNCR) United States $2.374B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.281B 11.04
Corcept Therapeutics (CORT) United States $2.042B 18.80
Revolution Medicines (RVMD) United States $1.899B 0.00
Cronos Group (CRON) Canada $1.889B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.889B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.600B 11.11
USANA Health Sciences (USNA) United States $1.577B 14.86
Heron Therapeutics (HRTX) United States $1.452B 0.00
Zogenix (ZGNX) United States $1.367B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.268B 12.09
Trillium Therapeutics (TRIL) Canada $1.249B 0.00
Indivior (INVVY) United States $1.177B 14.58
Karyopharm Therapeutics (KPTI) United States $1.173B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.135B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.071B 0.00
Translate Bio (TBIO) United States $1.061B 0.00
Esperion Therapeutics (ESPR) United States $1.039B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.951B 592.13
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
VAXART, INC (VXRT) United States $0.806B 0.00
Endo (ENDP) Ireland $0.726B 1.07
ImmunoGen (IMGN) United States $0.721B 0.00
Tilray (TLRY) Canada $0.717B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.701B 0.00
Collegium Pharmaceutical (COLL) United States $0.667B 0.00
Molecular Templates (MTEM) United States $0.652B 0.00
Flexion Therapeutics (FLXN) United States $0.618B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.609B 0.00
Radius Health (RDUS) United States $0.583B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.562B 0.00
Ocular Therapeutix (OCUL) United States $0.555B 0.00
Ardelyx (ARDX) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.548B 58.42
Aerie Pharmaceuticals (AERI) United States $0.544B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.532B 0.00
Altimmune (ALT) United States $0.456B 0.00
Organogenesis Holdings (ORGO) United States $0.437B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Harpoon Therapeutics (HARP) United States $0.413B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.406B 20.23
Akebia Therapeutics (AKBA) United States $0.383B 0.00
Redhill Biopharma (RDHL) Israel $0.382B 0.00
TherapeuticsMD (TXMD) United States $0.368B 0.00
MEI Pharma (MEIP) United States $0.366B 0.00
DURECT (DRRX) United States $0.355B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.354B 8.77
Innate Pharma SA (IPHYF) France $0.324B 0.00
IMV INC (IMV) Canada $0.324B 0.00
PROFOUND MEDICL (PROF) Canada $0.322B 0.00
Jounce Therapeutics (JNCE) United States $0.321B 15.19
Concert Pharmaceuticals (CNCE) United States $0.314B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.263B 0.00
Xeris Pharmaceuticals (XERS) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.250B 0.00
Nature's Sunshine Products (NATR) United States $0.250B 24.60
Lannett Co Inc (LCI) United States $0.242B 5.62
KalVista Pharmaceuticals (KALV) United States $0.240B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.232B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.219B 0.00
CASI Pharmaceuticals (CASI) United States $0.217B 0.00
Heat Biologics (HTBX) United States $0.205B 0.00
OptiNose (OPTN) United States $0.204B 0.00
Otonomy (OTIC) United States $0.183B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.161B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.155B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.137B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.116B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.108B 0.00
Champions Oncology (CSBR) United States $0.106B 0.00
MediWound (MDWD) Israel $0.103B 0.00
Aclaris Therapeutics (ACRS) United States $0.102B 0.00
Lipocine (LPCN) United States $0.101B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Biomerica (BMRA) United States $0.083B 0.00
CTI BioPharma (CTIC) United States $0.082B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
Hemispherx BioPharma (AIM) United States $0.078B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.077B 0.00
Novan (NOVN) United States $0.071B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.065B 0.00
Addex Therapeutics (ADXN) Switzerland $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.063B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Recro Pharma (REPH) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.27
CV Sciences (CVSI) United States $0.050B 0.00
India Globalization Capital (IGC) United States $0.050B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.049B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
IsoRay (ISR) United States $0.048B 0.00
Onconova Therapeutics (ONTX) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
GTx (ONCT) United States $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.20
ProPhase Labs (PRPH) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
Sundial Growers (SNDL) Canada $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.025B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 25.73
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
JanOne (JAN) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00